Assistant Professor of Medicine Emory University School of Medicine
This session will focus on the management of non-alcoholic fatty liver disease (NAFLD) with a particular emphasis on the role of GLP-1 agonists and SGLT-2 inhibitors in treating this condition. The presentation will also review the epidemiology of non-alcoholic fatty liver disease and the initial steps in the evaluation and risk stratification of NAFLD patients presenting in a primary care setting.
Learning Objectives:
Evaluate and risk stratify patients with NAFLD
Advise patients regarding available treatment options and implement a treatment plan with the goal of achieving weight loss
Identify patients that require further evaluation by a Hepatologist